BIOTECHBRKTHRU THEME investors incur serious losses

Biotech Breakthroughs significantly underperformed today. It delivered -1.26% to close at 1228.32. During the last week it delivered -5.04% and saw a maximum drawdown of -5.04%.

[Theme constituents]

~BIOTECHBRKTHRU is currently in a bearish trend. The current bearish signal has generated a profit of +8.4% for investors in the last three months.

Trend

Monthly Performance

Alpha (outperformance)

Heatmap

Volatility

Return distribution

~BIOTECHBRKTHRU has been outperforming the SP500 index in recent time. It showed significant outperformance (compared to the SP500 index) from 26 Jan, 2017 to 19 Jul, 2018. Over the last 2 years 11 months and 14 days, ~BIOTECHBRKTHRU underperformed the SP500 index on 48% days. Which indicates that on days ~BIOTECHBRKTHRU underperforms the SP500 index, it's performance is marginally worse than on the days it outperforms the SP500 index.

During the last three months ~BIOTECHBRKTHRU was mostly loss making and delivered on average -0.21% per day. It's best return during this period (of +4.01%) was on Tuesday, 16 Oct, 2018. While it's worst loss in the same period (of -4.8%) was on Wednesday, 24 Oct, 2018. The longest stort-term trends during this period were 5 profitable and losing days. The bullish trend (which returned +4.15%) started on 30 Oct, 2018 and went on till 5 Nov, 2018 while the bearish trend (which returned -9.83%) started on 18 Oct, 2018 and went on till 24 Oct, 2018.

The last 12 months saw ~BIOTECHBRKTHRU's investors making profits in 8 months and incurring losses in 4 months. During the last year, ~BIOTECHBRKTHRU and SP500 index had the same number of profitable months. ~BIOTECHBRKTHRU was also a more risky investment than SP500 index as it's worst month in the last year, Oct 2018, returned -10.52% compared to -7.75% returned by SP500 index in Dec 2018. ~BIOTECHBRKTHRU and SP500 index, both had periods of 6 consecutive profitable months. It is interesting to note that both ~BIOTECHBRKTHRU and SP500 index significantly outperform during months when quarterly/annual results are announced.

Average investors who try to do a lot of trading will only make their brokers rich.
-- Michael Jenson

~BIOTECHBRKTHRU is currently seeing overall increase in volatility. In comparison, the SP500 index is seeing increase in volatility. During the last three months, there was a significant surge in ~BIOTECHBRKTHRU's volatility from 19 Sep, 2018 to 25 Oct, 2018. While there was a significant surge in the SP500 index's volatility from 19 Sep, 2018 to 29 Oct, 2018.

Advanced/professional short-term investors should note that ~BIOTECHBRKTHRU has significant positive skewness in it's return distribution. This indicates that investors can expect ~BIOTECHBRKTHRU to recover from drawdowns quickly. Which makes ~BIOTECHBRKTHRU a good candidate for investing on short-term bullish trends or even counter-trends hoping for a pull-back.

~BIOTECHBRKTHRU has more chance of extreme outcomes than the SP500 index. Therefore, ~BIOTECHBRKTHRU must receive a lower allocation than SP500 in your portfolio. SP500 index usually has shorter drawdown period than ~BIOTECHBRKTHRU.

Based on your interest in ~BIOTECHBRKTHRU you may find it interesting to know that AMRH, NSPR and AYTU have all shown remarkable performance and qualify to be on every investor's watchlist.